| Symbol |
Name |
|
ABCA3
|
ATP-binding cassette, sub-family A (ABC1), member 3
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCD2
|
ATP-binding cassette, sub-family D (ALD), member 2
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABCG5
|
ATP-binding cassette, sub-family G (WHITE), member 5
|
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACTN4
|
actinin, alpha 4
|
|
ADA
|
adenosine deaminase
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADM
|
adrenomedullin
|
|
ADM2
|
adrenomedullin 2
|
|
ADORA3
|
adenosine A3 receptor
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AFP
|
alpha-fetoprotein
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AHRR
|
aryl-hydrocarbon receptor repressor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AK1
|
adenylate kinase 1
|
|
AKAP10
|
A kinase (PRKA) anchor protein 10
|
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALAD
|
aminolevulinate dehydratase
|
|
ALB
|
albumin
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALDH5A1
|
aldehyde dehydrogenase 5 family, member A1
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
AMH
|
anti-Mullerian hormone
|
|
AMY1A
|
amylase, alpha 1A (salivary)
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL1
|
angiopoietin-like 1
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
APC
|
adenomatous polyposis coli
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3D
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D
|
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP7
|
aquaporin 7
|
|
AQP9
|
aquaporin 9
|
|
AR
|
androgen receptor
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARRB1
|
arrestin, beta 1
|
|
ARVCF
|
armadillo repeat gene deleted in velocardiofacial syndrome
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATXN2
|
ataxin 2
|
|
ATXN3
|
ataxin 3
|
|
AURKA
|
aurora kinase A
|
|
AVP
|
arginine vasopressin
|
|
AVPR1A
|
arginine vasopressin receptor 1A
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
B2M
|
beta-2-microglobulin
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2L1
|
BCL2-like 1
|
|
BCR
|
breakpoint cluster region
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP15
|
bone morphogenetic protein 15
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRS3
|
bombesin-like receptor 3
|
|
BSG
|
basigin (Ok blood group)
|
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1
|
|
C3
|
complement component 3
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1S
|
calcium channel, voltage-dependent, L type, alpha 1S subunit
|
|
CACNB4
|
calcium channel, voltage-dependent, beta 4 subunit
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP8AP2
|
caspase 8 associated protein 2
|
|
CASR
|
calcium-sensing receptor
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCNA1
|
cyclin A1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD14
|
CD14 molecule
|
|
CD163
|
CD163 molecule
|
|
CD177
|
CD177 molecule
|
|
CD1D
|
CD1d molecule
|
|
CD226
|
CD226 molecule
|
|
CD24
|
CD24 molecule
|
|
CD274
|
CD274 molecule
|
|
CD33
|
CD33 molecule
|
|
CD34
|
CD34 molecule
|
|
CD4
|
CD4 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD86
|
CD86 molecule
|
|
CDA
|
cytidine deaminase
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CERS1
|
ceramide synthase 1
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGA
|
chromogranin A
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CHRNE
|
cholinergic receptor, nicotinic, epsilon (muscle)
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
|
CLCN2
|
chloride channel, voltage-sensitive 2
|
|
CLDN14
|
claudin 14
|
|
CLDN18
|
claudin 18
|
|
CLDN4
|
claudin 4
|
|
CMA1
|
chymase 1, mast cell
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNTNAP2
|
contactin associated protein-like 2
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
COX3
|
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRNN
|
cornulin
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CST3
|
cystatin C
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSK
|
cathepsin K
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYCS
|
cytochrome c, somatic
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP3A7
|
cytochrome P450, family 3, subfamily A, polypeptide 7
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DCN
|
decorin
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEFB4A
|
defensin, beta 4A
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DMD
|
dystrophin
|
|
DNAJB11
|
DnaJ (Hsp40) homolog, subfamily B, member 11
|
|
DNM2
|
dynamin 2
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3L
|
DNA (cytosine-5-)-methyltransferase 3-like
|
|
DNPEP
|
aspartyl aminopeptidase
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DUOX2
|
dual oxidase 2
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
E2F1
|
E2F transcription factor 1
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ENDOG
|
endonuclease G
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETV4
|
ets variant 4
|
|
EVI5
|
ecotropic viral integration site 5
|
|
F11R
|
F11 receptor
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2RL2
|
coagulation factor II (thrombin) receptor-like 2
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGF9
|
fibroblast growth factor 9
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FLG
|
filaggrin
|
|
FLNA
|
filamin A, alpha
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FOXP3
|
forkhead box P3
|
|
FRAT2
|
frequently rearranged in advanced T-cell lymphomas 2
|
|
FTL
|
ferritin, light polypeptide
|
|
FTMT
|
ferritin mitochondrial
|
|
FTO
|
fat mass and obesity associated
|
|
FZD4
|
frizzled class receptor 4
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF9
|
growth differentiation factor 9
|
|
GGT2
|
gamma-glutamyltransferase 2
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIPR
|
gastric inhibitory polypeptide receptor
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLB1
|
galactosidase, beta 1
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
|
GLS
|
glutaminase
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GPA33
|
glycoprotein A33 (transmembrane)
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPX3
|
glutathione peroxidase 3
|
|
GPX4
|
glutathione peroxidase 4
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GUCY1A2
|
guanylate cyclase 1, soluble, alpha 2
|
|
GYPC
|
glycophorin C (Gerbich blood group)
|
|
H2AFX
|
H2A histone family, member X
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBB
|
hemoglobin, beta
|
|
HDC
|
histidine decarboxylase
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGB1
|
high mobility group box 1
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HNRNPL
|
heterogeneous nuclear ribonucleoprotein L
|
|
HOGA1
|
4-hydroxy-2-oxoglutarate aldolase 1
|
|
HOXA9
|
homeobox A9
|
|
HOXB2
|
homeobox B2
|
|
HOXB4
|
homeobox B4
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
ICA1
|
islet cell autoantigen 1, 69kDa
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IER3
|
immediate early response 3
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFITM1
|
interferon induced transmembrane protein 1
|
|
IFN1@
|
interferon, type 1, cluster
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
|
IL10
|
interleukin 10
|
|
IL12B
|
interleukin 12B
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL17F
|
interleukin 17F
|
|
IL18
|
interleukin 18
|
|
IL19
|
interleukin 19
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL7R
|
interleukin 7 receptor
|
|
INHA
|
inhibin, alpha
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRS1
|
insulin receptor substrate 1
|
|
ISL1
|
ISL LIM homeobox 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNK3
|
potassium channel, two pore domain subfamily K, member 3
|
|
KCNMB1
|
potassium channel subfamily M regulatory beta subunit 1
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KHSRP
|
KH-type splicing regulatory protein
|
|
KIF20A
|
kinesin family member 20A
|
|
KIF6
|
kinesin family member 6
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KNG1
|
kininogen 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT20
|
keratin 20, type I
|
|
LCN2
|
lipocalin 2
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEP
|
leptin
|
|
LEPQTL1
|
Leptin, serum levels of
|
|
LILRA3
|
leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTA
|
lymphotoxin alpha
|
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1
|
|
MAOA
|
monoamine oxidase A
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MBL3P
|
mannose-binding lectin family member 3, pseudogene
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC3R
|
melanocortin 3 receptor
|
|
MC4R
|
melanocortin 4 receptor
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR145
|
microRNA 145
|
|
MIR199A1
|
microRNA 199a-1
|
|
MIR21
|
microRNA 21
|
|
MIR2861
|
microRNA 2861
|
|
MIR328
|
microRNA 328
|
|
MIR451A
|
microRNA 451a
|
|
MIR519C
|
microRNA 519c
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MLH1
|
mutL homolog 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPG
|
N-methylpurine-DNA glycosylase
|
|
MPHOSPH9
|
M-phase phosphoprotein 9
|
|
MPO
|
myeloperoxidase
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH2
|
mutS homolog 2
|
|
MSTN
|
myostatin
|
|
MT2A
|
metallothionein 2A
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC3A
|
mucin 3A, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
MUTYH
|
mutY homolog
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
MYOT
|
myotilin
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCF2
|
neutrophil cytosolic factor 2
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NHEJ1
|
nonhomologous end-joining factor 1
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NPPB
|
natriuretic peptide B
|
|
NPPC
|
natriuretic peptide C
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NPY
|
neuropeptide Y
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
OSM
|
oncostatin M
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
OXTR
|
oxytocin receptor
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PBOV1
|
prostate and breast cancer overexpressed 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCYOX1
|
prenylcysteine oxidase 1
|
|
PDIA2
|
protein disulfide isomerase family A, member 2
|
|
PEAR1
|
platelet endothelial aggregation receptor 1
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PER3
|
period circadian clock 3
|
|
PGC
|
progastricsin (pepsinogen C)
|
|
PGF
|
placental growth factor
|
|
PHLPP1
|
PH domain and leucine rich repeat protein phosphatase 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PITX2
|
paired-like homeodomain 2
|
|
PLAGL2
|
pleiomorphic adenoma gene-like 2
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLIN1
|
perilipin 1
|
|
PLK1
|
polo-like kinase 1
|
|
PMCH
|
pro-melanin-concentrating hormone
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
PNP
|
purine nucleoside phosphorylase
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
PON1
|
paraoxonase 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDM16
|
PR domain containing 16
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRH1
|
proline-rich protein HaeIII subfamily 1
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PRTN3
|
proteinase 3
|
|
PSEN1
|
presenilin 1
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTK2
|
protein tyrosine kinase 2
|
|
QDPR
|
quinoid dihydropteridine reductase
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RARB
|
retinoic acid receptor, beta
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RECQL4
|
RecQ protein-like 4
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REN
|
renin
|
|
RET
|
ret proto-oncogene
|
|
REV1
|
REV1, polymerase (DNA directed)
|
|
RFC1
|
replication factor C (activator 1) 1, 145kDa
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS7
|
regulator of G-protein signaling 7
|
|
RGS9
|
regulator of G-protein signaling 9
|
|
RMRP
|
RNA component of mitochondrial RNA processing endoribonuclease
|
|
RNASE2
|
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)
|
|
ROBO3
|
roundabout, axon guidance receptor, homolog 3 (Drosophila)
|
|
RRM2
|
ribonucleotide reductase M2
|
|
RRP9
|
ribosomal RNA processing 9, small subunit (SSU) processome component, homolog (yeast)
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
S100A2
|
S100 calcium binding protein A2
|
|
S100B
|
S100 calcium binding protein B
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SDC1
|
syndecan 1
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SFTPB
|
surfactant protein B
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SI
|
sucrase-isomaltase (alpha-glucosidase)
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC16A4
|
solute carrier family 16, member 4
|
|
SLC18A1
|
solute carrier family 18 (vesicular monoamine transporter), member 1
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A2
|
solute carrier family 2 (facilitated glucose transporter), member 2
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC37A4
|
solute carrier family 37 (glucose-6-phosphate transporter), member 4
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC6A6
|
solute carrier family 6 (neurotransmitter transporter), member 6
|
|
SLC7A1
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMC3
|
structural maintenance of chromosomes 3
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOST
|
sclerostin
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPAST
|
spastin
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SSTR1
|
somatostatin receptor 1
|
|
SSTR2
|
somatostatin receptor 2
|
|
SSTR5
|
somatostatin receptor 5
|
|
ST3GAL1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
|
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1
|
|
STARD4
|
StAR-related lipid transfer (START) domain containing 4
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STIM1
|
stromal interaction molecule 1
|
|
STK11
|
serine/threonine kinase 11
|
|
STMN1
|
stathmin 1
|
|
STX1A
|
syntaxin 1A (brain)
|
|
SULT1E1
|
sulfotransferase family 1E, estrogen-preferring, member 1
|
|
SULT2A1
|
sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1
|
|
TARDBP
|
TAR DNA binding protein
|
|
TAZ
|
tafazzin
|
|
TBP
|
TATA box binding protein
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERT
|
telomerase reverse transcriptase
|
|
TF
|
transferrin
|
|
TFAP2C
|
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
THBS1
|
thrombospondin 1
|
|
THRSP
|
thyroid hormone responsive
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLX1
|
T-cell leukemia homeobox 1
|
|
TMEM121
|
transmembrane protein 121
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF10C
|
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
|
|
TNFRSF10D
|
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TNS1
|
tensin 1
|
|
TNS2
|
tensin 2
|
|
TNS3
|
tensin 3
|
|
TNS4
|
tensin 4
|
|
TP53
|
tumor protein p53
|
|
TP53AIP1
|
tumor protein p53 regulated apoptosis inducing protein 1
|
|
TP63
|
tumor protein p63
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSPO
|
translocator protein (18kDa)
|
|
TTR
|
transthyretin
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
UCP1
|
uncoupling protein 1 (mitochondrial, proton carrier)
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
ULBP3
|
UL16 binding protein 3
|
|
UMOD
|
uromodulin
|
|
UNC5B
|
unc-5 homolog B (C. elegans)
|
|
UPK3A
|
uroplakin 3A
|
|
VCL
|
vinculin
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
VWF
|
von Willebrand factor
|
|
WFIKKN2
|
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2
|
|
WISP2
|
WNT1 inducible signaling pathway protein 2
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
WT1
|
Wilms tumor 1
|
|
XIST
|
X inactive specific transcript (non-protein coding)
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZFP36
|
ZFP36 ring finger protein
|
